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The highly potent antitumor agent ansamitocin P3 is a macrolactam isolated from Actinosynnema pretiosum ATCC 31565. A 
120-kb DNA fragment was previously identified as the ansamitocin biosynthetic gene cluster, and contains genes for polyke-
tide assembly, precursor synthesis, post-polyketide synthesis modification, and regulation. Within the biosynthetic gene cluster, 
asm8 encodes an 1117-amino-acid protein with a high degree of similarity to the large ATP-binding LuxR family-type regula-
tors. In the current study, we determined that inactivation of asm8 by gene replacement in ATCC 31565 resulted in the com-
plete loss of ansamitocin production, and that complementation with a cloned asm8 gene restored ansamitocin biosynthesis. 
Interestingly, the disruption of asm8 decreased the transcription of genes responsible for 3-amino-5-hydroxybenzoate (AHBA) 
formation, the starter unit required for ansamitocin biosynthesis. Subsequently, feeding of exogenous AHBA to the asm8 mu-
tant restored ansamitocin biosynthesis, which showed that Asm8 is a specific positive regulator in AHBA biosynthesis. In ad-
dition, investigation of asm8 homologs identified two new ansamitocin producers, and inactivation of the asm8 homolog in A. 
pretiosum ATCC 31280 abolished ansamitocin production in this strain. Characterization of the positive regulator Asm8 and 
discovery of the two new ansamitocin producers paves the way for further improving production of this important antitumor 
agent. 
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Like their plant-derived maytansinoid counterparts [1], an-
samitocins (e.g., ansamitocin P-3; AP-3) demonstrate potent 
antitumor activity by specifically inhibiting eukaryotic mi-
tosis [2]. The antibody-conjugated drug Kadcyla uses may-
tansinoid as the active compound, and was approved in 
February 2013 by the United States Food and Drug Admin-
istration for treating breast cancer [3]. Produced by Acti-
nosynnema pretiosum subsp. auranticum ATCC 31565 
(hereafter referred to as ATCC 31565), these microbial me-
tabolites belong to an important class of polyketide natural 
products called ansamycins [2]. All ansamycin antibiotics 
are macrolactams, and are characterized by an amide-linkage- 
terminated benzoic acid or a naphthalenic chromophore 
bridged by an aliphatic polyketide. Typical ansamycins in-
clude rifamycin, ansamitocin, and macbecins.  
Biosynthesis of ansamycin antibiotics involves the for-
mation of 3-amino-5-hydroxybenzoate (AHBA) as the 
starter unit for the assembly of the polyketide chain. The 
first three steps of the AHBA pathway are very similar to 
the shikimate pathway, but later steps are differentiated by 
the introduction of glutamine-derived nitrogen, to give 
3,4-dideoxy-4-amino-D-arabino-heptulosonic acid 7-phos-      
phate (aminoDAHP). Cyclization and dehydration of amino- 
DAHP generates 5-deoxy-5-amino-3-dehydroquinic acid 
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(aminoDHS), which is finally aromatized by the enzyme 
AHBA synthase to give AHBA [4,5]. Sequence analysis of 
the ansamitocin biosynthetic gene cluster identified 52 open 
reading frames in two separate regions of 83 and 12 kb [6]. 
Among these genes, asm47, -23, -44, -45, and -22 are hom-
ologs of rifG, -J, -L, -M, and -N, respectively, from the ri-
famycin biosynthetic gene cluster [6]. Both asm24 and 
asm43 are homologs of rifK [5] (Figure 1A). Moreover, 
genes asm43–47 form an operon, and asm23 and 24 are 
transcribed from a divergent promoter region (Figure 1B). 
The biosynthetic mechanism of ansamitocins has been 
studied extensively [6–9]. However, little is known about 
the regulation of ansamitocin biosynthesis. Previous se-
quencing of the ansamitocin biosynthetic gene cluster has 
revealed the presence of a set of regulatory genes. Three 
genes, asm2, -29, and -34, encode TetR family proteins, 
while asm31, -39, and -40 encode a sigma factor, sigma 
factor antagonist, and anti-sigma antagonist, respectively. 
The protein encoded by asm18 is homologous to a SARP 
(Streptomyces antibiotic regulatory protein) family protein. 
The remaining two proteins, encoded by asm8 and asm48, 
are similar to LuxR or LAL family (large ATP-binding reg-
ulator of the LuxR family) regulatory proteins.  
A previous study showed that in-frame deletion of asm2 
caused an over-production of ansamitocins [10]. More in-
terestingly, AP-3 production was also increased by constitu-
tive over-expression of asm2 and asm39 [11].  
Here, the function of asm8 was studied through gene in-
activation, complementation, transcriptional analysis, and 
feeding experiments. Results showed that asm8 is a positive 
regulator of ansamitocin production, specifically the for-
mation of the AHBA starter unit, in ATCC 31565. Further 
investigation of asm8 homologs through gene comparison 
and gene inactivation identified two additional novel an-
samitocin producers. 
1  Materials and methods 
1.1  Bacterial strains, cloning vectors, and cultivation  
Strains and plasmids used in this study are listed in Table 
S1. Actinosynnema strains were cultivated at 30°C and 220    
r min1 in liquid tryptic soy broth medium (supplemented 
with 1% yeast extract and 10.3% sucrose) for 2 d. Fermen-
tation was carried out on yeast and malt extract with glucose 
(YMG) agar plates at 30°C for 7 d. The same medium was 
supplemented with apramycin when used for growth and/or 
metabolite production of the asm8 mutant, PW201. E. coli 
strains DH10B (Invitrogen, New York) and ET12567 
(pUZ8002) were used as hosts for plasmid construction and  
E. coli-Streptomyces conjugation [12], respectively. pJTU1278 
was used for gene inactivation [13], and pBluescript KS() 
(Agilent Technologies Inc., Santa Clara, CA, USA) and 
pUC18 (Thermo Fisher Scientific Inc., Waltham, MA, USA) 
were used for gene cloning and DNA sequencing. pRSET-B 




Figure 1  Proposed biosynthetic pathway of AHBA, and organization of the AHBA biosynthetic gene cluster. A, Proposed pathway for AHBA biosynthesis. 
Gln (glutamine), aminoF6P (3-amino-3-deoxy-D-fructose 6-phosphate), iminoE4P (1-deoxy-1-imino-D-erythrose 4-phosphate), PEP (phosphoenolpyruvate), 
aminoDAHP (3,4-dideoxy-4-amino-D-arabino-heptulosonic acid 7-phosphate), aminoDHQ (5-deoxy-5-amino-3-dehydroquinic acid), aminoDHS 
(5-deoxy-5-amino-3-dehydroshikimic acid), AHBA (3-amino-5-hydroxybenzoate). B, Organization of AHBA biosynthetic gene cluster (asm21–24 and 
asm42–47) in ATCC 31565. 
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in E. coli. Shuttle vectors pIB139 [14] and pSET152 [15] 
were used for gene complementation.  
1.2  Genetic manipulation 
Standard genetic techniques using E. coli and in vitro DNA 
manipulation were performed as described by Sambrook et 
al. [16]. Recombinant DNA techniques in Actinosynnema 
species and isolation of Actinosynnema DNA were per-
formed as described previously [17]. 
1.3  Disruption of asm8 using Redirect Technology 
A 7.0-kb Sac I/BamH I fragment from cosmid 3C11 [6] was 
cloned into pJTU1278, to generate pJTU851. The 3.40-kb 
asm8 gene within pJTU851 was replaced with an 
aac3(IV)-oriT cassette, to generate pJTU852, using Redirect 
Technology according to a previously published method 
[18]. The aac(3)IV-oriT cassette was amplified from pIJ773 
using primer pair asm8-tgt-F (5′-ATGCGGCTGGTGGAC- 
CGCGACGGGCAGTGCGAGGCGCTGattccggggatccgtc-  
gacc-3′) and asm8-tgt-R (5′-TCAGGCGGGGGTGGTCA- 
GGTCGGCGTGCAGGGTGGTGGGtgtaggctggagctgcttc-  
3′) (pIJ773 homologous sequences are in lowercase). For a 
marker-free gene replacement, pJTU852 was digested with 
Xba I and then re-ligated to generate pJTU886, in which the 
aac(3)IV-oriT cassette was replaced with an 81-bp “scar” 
sequence. pJTU886 was used in conjugation with an apra-
mycin-resistant asm8 mutant to generate the marker-free 
mutant PW1, which was verified by PCR amplification with 
the primers asm8-Det-F (5′-AGTGGGGGTGCGGTGGT- 
3′) and asm8-Det-R (5′-CTGGTCGGGTCGGGGTC-3′).  
1.4  Trans-complementation of the mutant PW1 with 
cloned asm8 
For the complementation of the PW1 Δasm8 mutant, a 
3.80-kb Nru I fragment from pJTU851, containing asm8 
and its promoter region, was cloned into pSET152. The 
resulting plasmid, pJTU3101, was then transferred by con-
jugation from E. coli ET12567 (pUZ8002) to PW1, as de-
scribed previously [19].  
1.5  Fermentation, purification, and analysis of ansa-     
mitocins 
Seven-day YMG agar plate cultures of the wild-type ATCC 
31565 strain and the PW1 mutant were extracted with ethyl 
acetate. The extract was concentrated under reduced pres-
sure, and was further extracted with 1 mL methanol. The 
methanol extract was analyzed by liquid chromatog-
raphy-mass spectrometry (LC-MS) using an Agilent 1100 
series LC/MSD Trap system [8]. High performance liquid 
chromatography (HPLC) was operated at a flow rate of 0.45 
mL min1 with methanol-water (70/30, v/v) on a Calesil 
ODS-100 (4.6 mm×150 mm, 5 μm) column. An ion-trap 
mass spectrometer was operated with the electrospray ioni-
zation source in positive ion mode. The drying gas flow was 
6 L min1, and the nebulizer pressure was 30 psi. The drying 
gas temperature was 325°C. 
1.6  RNA isolation and quantitative reverse transcrip-
tion-polymerase chain reaction (qRT-PCR) analysis  
A two-day culture of A. pretiosum mycelia was collected 
from YMG agar plates and disrupted using glass beads 
(150–212 m, Sigma) in a Precellys homogenizer (6500   
r min1, 2×20 s; Peqlab). RNA was isolated using a Total 
RNA Isolation Kit (SBS Genetech, Shanghai) and then treated 
with RNase-free DNase I (Thermo Fisher Scientific Inc.) to 
eliminate possible chromosomal DNA contamination.  
Equal amounts of purified RNA (3 g) were used to 
generate cDNA using RevertAid H Minus reverse tran-
scriptase and random hexamer primers, as described by the 
manufacturer (Thermo Fisher Scientific Inc.). The condi-
tions were as follows: first strand cDNA synthesis, 42°C for 
1 h, followed by 70°C for 10 min. One microliter of synthe-
sized cDNA was then used as template for each qRT-PCR, 
which was performed following the Maxima SYBR 
Green/ROX qPCR master mix protocol (Thermo Fisher Sci-
entific Inc.). The conditions were as follows: 50°C for 20 s, 
95°C for 10 min, followed by 40 cycles of 95°C for 15 s 
and 60°C for 1 min. The DNA gyrase gene gyrB was used 
as an internal control. The transcription of 45 genes in the 
biosynthetic gene cluster was analyzed.  
2  Results 
2.1  Asm8 is positively involved in ansamitocin biosyn-
thesis  
To investigate the function of asm8, an in-frame deletion of 
asm8 was performed in E. coli using Redirect Technology 
[18], followed by two rounds of conjugation with ATCC 
31565 (Figure 2A). Three thiostrepton-sensitive apramycin-      
sensitive (ThioSAprS) mutants (designated PW1-1–PW1-3) 
were obtained. Total genomic DNA was extracted from the 
mutants and the wild-type was compared by PCR. The 
wild-type gave a 3.80-kb amplified product, whereas am-
plicons from the mutants were only 0.60 kb (Figure 2B), 
confirming that a 3354-bp internal DNA fragment, corre-
sponding to asm8, had been replaced by an 81-bp scar 
fragment in the mutant genomes. ATCC 31565 and the  
PW1 mutants were incubated in fermentation medium for 7 d. 
The fermentation broths were then analyzed by LC-MS. 
AP-3, with a retention time of 19.7 min and an m/z of 635, 
was not detected in the fermentation broths of the PW1 mu-
tants (Figure 2C). 
To verify that the loss of AP-3 was caused only by the 
asm8 inactivation, mutant PW1 was trans-complemented  
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Figure 2  Schematic representation of asm8 inactivation and results of HPLC analysis of antibiotic production. A, Schematic representation of asm8 dis-
ruption. B, PCR analysis of wild-type and the PW1 mutant using primers asm8-Det-F and asm8-Det-R. C, HPLC analysis of the fermentation broths of 
wild-type ATCC 31565, mutant PW1, and PW1 complemented with cloned asm8 on pJTU3101. The peaks corresponding to AP-3 are marked by a dotted 
line.  
with a cloned 3.80-kb DNA fragment containing asm8 and 
its 280-bp upstream region. Plasmid pJTU3101, carrying 
the 3.80-kb fragment, was introduced into PW1 by conjuga-
tion. AP-3 productivity in the complemented mutant strain 
was restored to 30% of the wild-type (ATCC 31565) level 
(Figure 2C). The successful trans-complementation of PW1 
verified that asm8 is a pathway-specific activator of ansam-
itocin biosynthesis, and that the upstream 280-bp region of 
asm8 contains the native promoter in ATCC 31565.  
2.2  Severely reduced transcription of AHBA biosyn-
thetic genes in PW1  
The effect of asm8 mutation on ansamitocin production was 
further analyzed at the transcription level by qRT-PCR. The 
45 genes putatively related to ansamitocin biosynthesis 
were chosen for transcription analysis. Total RNA from 
two-day cultures of the wild-type and PW1 mutant were 
extracted and analyzed by qRT-PCR. Surprisingly, the 
transcription levels of asm23, -24, -43, -44, -45, -46, and 
-47 were severely reduced in PW1, whereas transcription 
levels of the genes responsible for polyketide assembly, 
methoxymalonyl-ACP biosynthesis, post-PKS modification, 
and regulation were not affected. Other than asm46, the 
genes showing reduced expression in PW1 are all involved 
in AHBA biosynthesis [20] (Figure 3). In addition, disrup-
tion of asm46 had no effect on AP-3 production (data not 
shown).  
2.3  Feeding with AHBA restored ansamitocin biosyn-
thesis 
The qRT-PCR analysis suggested that Asm8 specifically 
regulates the expression of the AHBA biosynthetic genes, 
rather than acting on the transcription of other biosynthetic 
genes. More supporting evidence was obtained from feeding 
experiments, whereby exogenous AHBA was fed to cultures 
of the PW1 mutant strain. PW1 was cultivated in fermenta-
tion medium supplemented with 1, 10, or 20 mg L1 AHBA. 
As shown in Figure 4, the production level of AP-3 in PW1 
gradually increased in proportion to the amount of exoge-
nous AHBA added to the fermentation broths. 
2.4  Identification of asm8 homologs and two new an-
samitocin producers  
BLAST analysis of Asm8 against the database identified 
homologous protein Amir_3178 in Actinosynnema mirum 
DSM 43827, which had an identity of 77%. As the genome 
sequence of DSM 43827 is available [21], the flanking se-
quences of asm8 and amir_3178 were compared. A strik-
ingly high level of sequence similarity and organization, 
especially for the ansamitocin biosynthetic genes, was ob-
served between ATCC 31565 and DSM 43827 (Figure S1 
in Supporting Information). Moreover, genes homologous 
to the AHBA-specific genes asm43–47 were also identified, 
not only in DSM 43827, but also in A. pretiosum ATCC 
31280 [22], a strain known for ansamycin-type macbecin  
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Figure 3  Transcriptional analysis of ansamitocin biosynthetic genes in PW1 compared with ATCC 31565. Transcription levels were determined by 
qRT-PCR, and putative AHBA biosynthesis genes are indicated in bold. 
 
Figure 4  Feeding of exogenous AHBA to the PW1 mutant. The level of AP-3 production by the PW1 mutant was analyzed by HPLC when PW1 was 
cultivated in fermentation medium supplemented with 0, 1, 10, or 20 mg L1 exogenous AHBA. 
 
production (Figure S1). This gene organization suggested 
that the ansamitocin biosynthetic gene cluster may be pre-
sent in the ATCC 31280 genome.  
Several pairs of primers specific for the ansamitocin bi-
osynthetic genes were used to try and PCR amplify the cor-
responding genes from ATCC 31280. The resultant prod-
ucts were sequenced and found to be identical to the ho-
mologous genes in ATCC 31565 (data not shown). In addi-
tion, all the three Actinosynnema strains were cultivated on 
YMG agar plates for 7 d, and the plates were then extracted 
with ethyl acetate for LC-MS analysis. Interestingly, peaks 
with the same retention time and mass as AP-3 were de-
tected in both ATCC 31280 and DSM 43827 (Figure 5A), 
confirming the identification of two new ansamitocin- 
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Figure 5  Detection of ansamitocins in the fermentation broths of ATCC 31280 and DSM 43827. A, LC-MS analysis of ansamitocins. The peaks corre-
sponding to AP-3 are indicated by a dotted line. B, AP-3 production in ATCC 31280, an amir_3178(31280) mutant, an amir_3178(31280) mutant comple-
mented with cloned asm8, and an amir_3178(31280) mutant supplemented with exogenous AHBA. Gene amir_3178(31280) was homologous to asm8 from 
ATCC 31280. C, AP-3 production in DSM 43827 and the amir_3178 mutants. Gene amir_3178 is homologous to asm8 from DSM 43827. 
producing strains. 
2.5  Inactivation of genes homologous to asm8 in ATCC 
31280 and DSM 43827  
In strain ATCC 31280, a gene homologous to asm8 was 
also identical to amir_3178 from DSM 43827, and was 
subsequently named amir_3178(31280). Gene amir_3178 
(31280) was inactivated by gene replacement in ATCC31280 
(Figure S2), and the production of AP-3 was completely 
abolished (Figure 5B). As expected, feeding with exoge-
nous AHBA recovered the AP-3 productivity of the 
amir_3178(31280) mutant. A trans-complemented mutant 
with cloned asm8 expressed from plasmid pJTU3101 had 
restored AP-3 productivity.  
Similar gene inactivation of asm8 homologous gene 
amir_3178 was also performed in DSM 43827 (Figure S3). 
Even though amir_3178 from DSM 43827 was identical to 
amir_3178(31280), the amir_3178 deletion mutant was 
surprisingly found to be capable of producing AP-3, albeit 
with a reduced yield of 60%–70% of the wild-type level 
(Figure 5C).  
3  Discussion 
The LAL family regulatory proteins are characterized by a 
LuxR-type pattern, consisting of a helix-turn-helix DNA-      
binding motif (~65 amino acids) at the C terminus, and a 
distinctive P-loop at the N-terminus, which is specific for an 
ATP-binding site. With a size of up to 116 kD, Asm8 fits 
the profile of LAL family proteins, and has a high degree of 
sequence similarity to a number of Streptomyces regulators, 
such as GdmRII from S. hygroscopicus 17997 [23], and 
AveR from S. avermitilis K139 [24], which are pathway-      
specific transcriptional activators of geldanamycin biosyn-
thesis and avermectin biosynthesis, respectively.  
Our experiments demonstrated for the first time that the 
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transcriptional activator gene asm8 is required for AP-3 
production, and specifically controls the biosynthesis of the 
AHBA starter unit. Although most of the antibiotic biosyn-
thetic gene clusters from actinomycetes have one or more 
regulatory genes [25], the presence of regulators controlling 
a complete set of genes with designated functions, such as 
precursor biosynthesis genes, is rare.  
Lechner et al. [26] identified a LuxR regulatory gene, 
salR2, in the salinosporamide biosynthetic gene cluster from 
Salinispora tropica; this gene is specifically involved in the 
formation of the halogenated precursor chloroethylmalonyl-       
CoA. When the salR2 mutant was supplemented with in-
termediate 4-chlorocrotonic acid, the productivity of salinos- 
poramide was restored. In the clavulanic acid biosynthetic 
gene cluster, a LysR transcriptional regulator, ClaR, was 
specific for the expression of genes in the downstream steps 
of clavulanic acid production, i.e., in the conversion of cla-
vaminic acid to clavulanic acid [27].  
Transcriptional analysis using qRT-PCR determined that 
the transcription of seven genes was significantly reduced 
(Figure 3), six of which were implicated in AHBA biosyn-
thesis (Figure 1A). asm46 was not related to ansamitocin 
biosynthesis (data not shown). Moreover, the transcription 
of asm22, encoding a putative kinase and homologous to rifN, 
was not affected. Even though homologs of asm22 are pre-
sent in all identified AHBA biosynthetic gene sets [28], its 
involvement in AHBA formation in ATCC 31565 needs to be 
further confirmed, either through gene inactivation or by in 
vitro enzymatic catalysis with the substrate kanosamine.  
To date, the negative regulatory gene asm2 and the posi-
tive regulatory gene asm8 are the only two genes character-
ized among the nine putative regulatory genes within the 
previously sequenced region [6]. Recently, eight more reg-
ulatory genes were identified by sequencing the 30-kb re-
gion between Cluster I and Cluster II (GenBank accession 
number of HQ441578) (Figure S1). The AP-3 yield was 
nearly doubled in a mutant with the 30-kb region deleted 
(data not shown). Because there are 18 regulatory genes 
within the 120-kb ansamitocin biosynthetic gene cluster, the 
biosynthesis of ansamitocin is assumed to be stringently 
regulated, which might cause difficulties for increasing the 
titer of ansamitocin.  
Further investigation into the functions of other regula-
tory genes will assist with boosting the expression of an-
samitocin biosynthetic genes, and ultimately increasing the 
titer. Already, introducing the cloned asm8 plasmid con-
struct into the wild-type ATCC 31565 strain has been 
shown to increase the AP-3 titer. Moreover, the identifica-
tion of ATCC 31280 and DSM 43827 as new ansamitocin 
producers may provide better starting candidates for genetic 
manipulation and titer improvement.  
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Figure S1  Gene organization in the regions flanking asm8 and its homologs in A. pretiosum ATCC 31565 and ATCC 31280, and in A. mirum DSM 43827.  
Figure S2  Disruption of amir_3178(31280) in ATCC 31280. A, Schematic representation of the inactivation of amir_3178(31280) in ATCC 31280. 
amir_3178(31280) was first replaced by an apramycin resistance gene, aac(3)IV, through Redirect Technology, and then replaced by an 81-bp scar fragment. 
B, PCR amplification of the DNA templates from amir_3178 (31280) mutants, designated PW11.  
Figure S3  Deletion of amir_3178 in DSM 43827. A, Schematic representation of the inactivation of amir_3178 in DSM 43827. Gene amir_3178 was 
replaced by an apramycin resistance gene, aac(3)IV, using Redirect Technology. B, PCR amplification with two pairs of primers (3178-det-F1/R1 and 
3178-det-F2/R2) using genomic DNA from the amir_3178 mutant, PW21, as the template. 
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